Commercial
Australia’s field force: evolving on fast forward
Australian pharma’s field force roles are changing fast and the new digital-first environment is driving a need for new approaches and new skillsets
Patients and Medical
From complexity to clarity in cell and gene therapy
One of the most exciting frontiers in medicine, cell and gene therapies are already offering breakthrough treatments and potential cures...
Commercial
Australia’s field force: evolving on fast forward
The pandemic has, it will surprise no one, upended traditional ways of working for pharma’s Australian field force. “I...
Latest
-
-
Patients and Medical
The future of Medical Affairs: A virtual Q&A with Charlotte Kremer
The Astellas head of medical affairs follows up with answers to questions during her virtual keynote earlier this year -
Access and Evidence
Survey results: Accelerating digital transformation during COVID-19
View the results of a survey of over 1000 pharma executives on the impact COVID-19 has had and will have on their operations -
Medical
Paying for cell and gene therapy - Is the future already here?
Multiple novel payment models for CGT are in development but an open and collaborative approach among all healthcare stakeholders is needed if the significant legal and practical barriers are to be overcome -
Patients and Medical
The future of medical congresses
The mega congresses of the past look likely to make way for more virtual, focused and, probably, hybrid physical/digital events
Most Popular
Katie Osborne, (Aug 18, 2020)
The mega congresses of the past look likely to make way for more virtual, focused and, probably, hybrid physical/digital events
Ulrich Neumann, (Aug 25, 2020)
Multiple novel payment models for CGT are in development but an open and collaborative approach among all healthcare stakeholders is needed if the significant legal and practical barriers are to be overcome
Andrew Stone, (Jul 28, 2020)
Key opinion leaders who evolve into the digital sphere to become digital opinion leaders will gain more reach and influence
Opinion
Jill Donahue, (Apr 14, 2020)
Merck's Thomas D’Hooghe shares his thoughts on passion, purpose, leading people and making a difference
Paul Simms, (Dec 19, 2019)
Celebrating winners makes genuine innovation visible, setting the bar higher and broadening the possibilities for pharma by showing what can be achieved
Commercial
-
Australia’s field force: evolving on fast forward
Australian pharma’s field force roles are changing fast and the new digital-first environment is driving a need for new approaches and new skillsets -
Customer centricity in a changed world
Pharma’s marketeers are having to rapidly change their approach to customers, field force roles and digital in the midst of the pandemic -
The changing nature of pharma sales: A conversation on many levels
The new approach to sales marries state of the art analytics with a classical approach to engagement -
Time to embrace social media
Patients are turning to social media as never before and pharma needs to catch up -
Has direct to consumer marketing in pharma had its day?
Outmoded and cliched DTC campaigns may be harming not helping pharma in the US
Access and Evidence
-
A burning desire to make a difference for patients
Annexus Health, eyeforpharma’s 2020 Health Start-up winner is on a mission for patients -
From reactive to predictive: Concerto’s new compositions
Artificial Intelligence has only just begun to unlock high value innovation. The latest predictive tools will break new ground, says Concerto HealthAI’s Jeff Elton -
Evolving HTA frameworks to accelerate innovation
Iterative evidence generation and demonstrating value over time could help unlock delays in getting cures out, saving more lives, says Janssen’s Clare Hague -
Can we afford to pay for future cures?
Medical innovation is racing ahead of healthcare’s ability to innovate on payments, but new ideas are emerging -
Advancing RWE together with academia
Pharma can realise the potential of RWE faster by collaborating more effectively with academia but first it must build trust
Patients and Medical
-
From complexity to clarity in cell and gene therapy
Breakthrough CGT therapies are coming thick and fast, now pharma must work on multiple fronts to educate non-specialist stakeholders about their exciting possibilities -
The future of Medical Affairs: A virtual Q&A with Charlotte Kremer
The Astellas head of medical affairs follows up with answers to questions during her virtual keynote earlier this year -
The future of medical congresses
The mega congresses of the past look likely to make way for more virtual, focused and, probably, hybrid physical/digital events -
Patient centricity: Mind the capacity gap
If pharma wants patients and patient groups capable of working with it at every stage of the drug development process it must listen to, and contribute to training and funding them -
What patients need right now
In the face of massive patient need, there’s plenty pharma can do to help. The crisis is also an opportunity for it to transform the way it works with patients.
Latest Videos
Upcoming events
View All EventsSeptember 2020
-
Pharma Marketing USA Virtual
Sep 29, 2020 - Sep 30, 2020
Digital Conference, Networking & Exhibition
October 2020
-
Pharma Marketing Europe Virtual
Oct 13, 2020 - Oct 14, 2020
Digital Conference, Networking & Exhibition
November 2020
December 2020
-
Pharma & Patient Summit USA Virtual
Dec 1, 2020 - Dec 4, 2020
Digital Conference, Networking & Exhibition
-
Pharma Awards USA
Dec 2, 2020 - Dec 2, 2020